ROS1 (C-ros oncogene 1) is an intracellular tyrosine kinase receptor known to have over 20 ROS1 gene rearrangements or fusions in ~2% of NSCLC cases, with CD74-ROS1 being the most common variant (38–54%). Here, ROS1 is linked to non-small cell lung carcinoma.